Screener
First Tracks Biotherapeutics Inc TRAX Total Current Liabilities
Total Current Liabilities at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $7,496 | $3,111 |
| Accrued expenses | 25,616 | 25,832 |
| Current portion of operating lease liability | — | 2,080 |
| Total current liabilities | 33,112 | 31,023 |
| Operating lease liability, net of current portion | — | 12,032 |
| Equity: | ||
| Net Parent Investment | 257,610 | 287,514 |
| Accumulated other comprehensive loss | (146) | (24) |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's total current liabilities?
- First Tracks Biotherapeutics Inc (TRAX) reported total current liabilities of $33.11M in Q1 2026.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about First Tracks Biotherapeutics Inc's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude